Loading clinical trials...
Loading clinical trials...
The purpose of this study is to obtain long-term clinical data from patients approximately 15 years after their first clinical event, who participated in the former BENEFIT 304747 study and were treated at least once within that study. This study will collect clinical information on the disease course, on disability, relapses, cognitive function over time, quality of life, depression, fatigue, resource use, and employment status. In addition, brain MRI is performed.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Medizinische Universität Graz
Graz, Styria, Austria
Landeskrankenhaus - Universitätskliniken Innsbruck
Innsbruck, Austria
CU Saint-Luc/UZ St-Luc
Bruxelles - Brussel, Belgium
UZ Gent
Ghent, Belgium
UZ Leuven Gasthuisberg
Leuven, Belgium
CHU de Liège
Liège, Belgium
Ottawa Hospital-General Campus
Ottawa, Ontario, Canada
CHUM - Hopital Hotel-Dieu
Montreal, Quebec, Canada
Montreal Neurological Hospital
Montreal, Quebec, Canada
Fakultni nemocnice Brno
Brno, Czechia
Start Date
September 29, 2017
Primary Completion Date
May 24, 2018
Completion Date
May 24, 2018
Last Updated
May 16, 2019
261
ACTUAL participants
Brain MRI
OTHER
Blood sampling
OTHER
Lead Sponsor
Bayer
NCT06276634
NCT07225504
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06809192